Publications by authors named "Julien Volet"

Claim this Profile
I
Impact on health-related quality of life deterioration-free survival of a first-line therapy combining nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial.
Emilie Charton, Jean-Baptiste Bachet, Pascal Hammel, Jérôme Desramé, Benoist Chibaudel, Julien Volet

Cancer Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
Thierry Conroy, Pascal Hammel, Mohamed Hebbar, Meher Ben Abdelghani, Alice C Wei, Julien Volet

N Engl J Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial.
Jean-Baptiste Bachet, Pascal Hammel, Jérôme Desramé, Aurélia Meurisse, Benoist Chibaudel, Julien Volet

Lancet Gastroenterol Hepatol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent insights in the therapeutic management of patients with gastric cancer.
Louis de Mestier, Sophie Lardière-Deguelte, Julien Volet, Reza Kianmanesh, Olivier Bouché

Dig Liver Dis· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FFCD-1004 Clinical Trial: Impact of Cytidine Deaminase Activity on Clinical Outcome in Gemcitabine-Monotherapy Treated Patients.
Cindy Serdjebi, Johan Gagnière, Jérôme Desramé, Francine Fein, Rosine Guimbaud, Julien Volet

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversible sarcopenia in patients with gastrointestinal stromal tumor treated with imatinib.
Frédérick Moryoussef, Marion Dhooge, Julien Volet, Coralie Barbe, Catherine Brezault

J Cachexia Sarcopenia Muscle· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of hepatitis B and C and sensibility of a selective screening questionnaire in patients receiving chemotherapy for solid tumors.
Mathilde Brasseur, Alexandra Heurgué-Berlot, Coralie Barbe, Cloé Brami, Jean-Baptiste Rey, Julien Volet

BMC Cancer· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors in patients with non resectable metastatic colorectal cancer in the era of targeted biotherapies: relevance of Köhne's risk classification.
Elise Desot, Louis de Mestier, Julien Volet, Christelle Delmas, Bruno Garcia

Dig Liver Dis· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[News in management of colorectal cancer at JFHOD 2012 meeting].
Julien Volet, Louis de Mestier, Florent Ehrhard, Olivier Bouché

Bull Cancer· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is palliative laparoscopic hyperthermic intraperitoneal chemotherapy effective in patients with malignant hemorrhagic ascites?
Louis de Mestier, Julien Volet, Elodie Scaglia, Simon Msika, Reza Kianmanesh

Case Rep Gastroenterol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis